Kallikrein Inhibition for Hereditary Angioedema

被引：7
|
作者：
Longhurst, Hilary J. [1 ]
机构：
[1] Barts Hlth NHS Trust, London, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 08期
关键词：
INTERNATIONAL WORKING GROUP; CONSENSUS REPORT; DEFICIENCY;
D O I：
10.1056/NEJMe1611929
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：788 / 789
页数：2
相关论文
共 50 条
  • [1] Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
    Riedl, Marc
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2010, 3 : S34 - S38
  • [2] Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
    Banerji, A.
    Busse, P.
    Shennak, M.
    Lumry, W.
    Davis-Lorton, M.
    Wedner, H. J.
    Jacobs, J.
    Baker, J.
    Bernstein, J. A.
    Lockey, R.
    Li, H. H.
    Craig, T.
    Cicardi, M.
    Riedl, M.
    Al-Ghazawi, A.
    Soo, C.
    Iarrobino, R.
    Sexton, D. J.
    TenHoor, C.
    Kenniston, J. A.
    Faucette, R.
    Still, J. G.
    Kushner, H.
    Mensah, R.
    Stevens, C.
    Biedenkapp, J. C.
    Chyung, Y.
    Adelman, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 717 - 728
  • [3] A review of kallikrein inhibitor lanadelumab in hereditary angioedema
    Hwang, Gloria
    Johri, Ansh
    Ng, Sally
    Craig, Timothy
    [J]. IMMUNOTHERAPY, 2019, 11 (11) : 937 - 944
  • [4] PLASMA KALLIKREIN AND PRORENIN IN PATIENTS WITH HEREDITARY ANGIOEDEMA
    PURDON, AD
    SCHAPIRA, M
    DEAGOSTINI, A
    COLMAN, RW
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1985, 105 (06): : 694 - 699
  • [5] Approaches to estimate plasma kallikrein inhibition levels required for attack prophylaxis in hereditary angioedema
    Sexton, D. J.
    Faucette, R.
    Kenniston, J.
    Wang, Y.
    Rong, H.
    [J]. ALLERGY, 2017, 72 : 596 - 596
  • [6] FDA approves kallikrein inhibitor to treat hereditary angioedema
    Thompson, Cheryl A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (02) : 93 - 93
  • [7] Ecallantide - Plasma kallikrein inhibitor, treatment of hereditary angioedema
    Revill, P.
    Mealy, N.
    [J]. DRUGS OF THE FUTURE, 2007, 32 (07) : 590 - 594
  • [8] Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
    Aygoeren-Puersuen, E.
    Bygum, A.
    Grivcheva-Panovska, V.
    Magerl, M.
    Graff, J.
    Steiner, U. C.
    Fain, O.
    Huissoon, A.
    Kinaciyan, T.
    Farkas, H.
    Lleonart, R.
    Longhurst, H. J.
    Rae, W.
    Triggiani, M.
    Aberer, W.
    Cancian, M.
    Zanichelli, A.
    Smith, W. B.
    Baeza, M. L.
    Du-Thanh, A.
    Gompels, M.
    Gonzalez-Quevedo, T.
    Greve, J.
    Guilarte, M.
    Katelaris, C.
    Dobo, S.
    Cornpropst, M.
    Clemons, D.
    Fang, L.
    Collis, P.
    Sheridan, W.
    Maurer, M.
    Cicardi, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 352 - 362
  • [9] A review of oral kallikrein inhibitor berotralstat for hereditary angioedema
    Gao, YingYu
    Hwang, Jacqueline
    Hwang, Gloria
    Craig, Timothy
    [J]. DRUGS OF TODAY, 2022, 58 (02) : 59 - +
  • [10] The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
    Levy, Jerrold H.
    O'Donnell, Penrose S.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (09) : 1077 - 1090
12345